ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)

ClinicalTrials.gov ID: NCT00000867

Public ClinicalTrials.gov record NCT00000867. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 2:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double Blind, Placebo-Controlled Trial of Memantine for AIDS Dementia Complex (ADC) as Concurrent Treatment With Antiretroviral Therapy

Study identification

NCT ID
NCT00000867
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
120 participants

Conditions and interventions

Interventions

  • Memantine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 1996
Primary completion
Not listed
Completion
Jun 30, 2001
Last update posted
Jun 9, 2013

1996 – 2001

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
UCLA CARE Center CRS Los Angeles California 90095
Ucsf Aids Crs San Francisco California 94110
Univ. of Miami AIDS CRS Miami Florida 33136
Queens Med. Ctr. Honolulu Hawaii 96816
Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu Hawaii 96816
Northwestern University CRS Chicago Illinois 60611
Cook County Hosp. CORE Ctr. Chicago Illinois 60612
The Univ. of Kentucky, Lexington A2405 CRS Lexington Kentucky 40536-0226
Bmc Actg Crs Boston Massachusetts 02118
Beth Israel Deaconess - East Campus A0102 CRS Boston Massachusetts 02215
Washington U CRS St Louis Missouri 63110
Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr. Omaha Nebraska 68198
SUNY - Buffalo, Erie County Medical Ctr. Buffalo New York 14215
Beth Israel Med. Ctr. (Mt. Sinai) New York New York 10003
Mt. Sinai Med. Ctr. (N.Y.) A1801 CRS New York New York 10029
Mt. Sinai Med. Ctr. A0404 CRS New York New York 10029
Univ. of Rochester ACTG CRS Rochester New York 14642
Hosp. of the Univ. of Pennsylvania CRS Philadelphia Pennsylvania 19104
University of Washington AIDS CRS Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000867, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 9, 2013 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000867 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →